
Manufacturing and Scientific Affairs

Mylan has a vast manufacturing platform in India which comprises nine 8 pharmaceutical ingredient (API), 6 oral solid dose (OSD) and 5 injectables manufacturing units that serve a number of markets around the world and produce medicines in a wide range of therapeutic areas.
Seventeen of Mylan’s facilities in India, including nine of its API facilities, are approved by the U.S. Food and Drug Administration (FDA). Many of the sites also are approved and regularly inspected by other regulatory authorities, including Australia's Therapeutic Goods Administration, the U.K.’s Medicines and Healthcare Products Regulatory Agency and the World Health Organization.
R&D Network
Mylan’s globally integrated R&D platform is expanding our product portfolio to satisfy unmet medical needs. We have < 3000 scientific affairs workforce who work collaboratively across multiple R&D centers around the world. About half of our scientific affairs workforce is based in India.
Locations
Find a Mylan India facility
Scientific Affairs
At Mylan, we are unconventional, visionary and bold. We see possibilities and bring them to life.
Quality
We have made Quality a habit. That’s why people across the world count on Mylan.
-
Questions?
Get more information on our products, services and Mylan Global Center locations.
Contact Us -
Business Opportunities
Do you have an opportunity or a collaboration idea?
Partner with us